Sign In
Buy MDGS
$2.36
+0 (+0%)
At Close: Jul 16, 2024
Medigus to Acquire 60% Interest of Commercial Property in Miami
09:23am, Thursday, 28'th Sep 2023
The company intends to establish its presence in Miami by acquiring, improving, renovating, developing and selling commercial properties
Medigus to Increase its Share in AI Systems to 36%
08:05am, Tuesday, 12'th Sep 2023
Tel Aviv, Israel, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and
Medigus: ParaZero Signs New Development Agreement with Latin American Drone Manufacturer Black Square
07:35am, Monday, 21'st Aug 2023
Tel Aviv, Israel, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in electric vehicle charging solutions, advanced medical solutions, and innovative interne
Best Penny Stocks To Buy: 3 High Volume Stocks To Watch Today
07:32pm, Friday, 23'rd Sep 2022 PennyStocks
High volume penny stocks to watch before next week.
The post Best Penny Stocks To Buy: 3 High Volume Stocks To Watch Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto
Best Penny Stocks To Buy: 3 High Volume Stocks To Watch Today
03:32pm, Friday, 23'rd Sep 2022
High volume penny stocks to watch before next week. The post Best Penny Stocks To Buy: 3 High Volume Stocks To Watch Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto
Medigus Announces Record 2022 First Half Financial Results
12:30pm, Friday, 23'rd Sep 2022 GlobeNewswire Inc.
Record Revenues of $34.95 million, up over 1,300% Y-o-Y Record Revenues of $34.95 million, up over 1,300% Y-o-Y
Medigus: Polyrizon Submitted an International Patent Application for its Platform Technologies
01:04pm, Monday, 12'th Sep 2022 GlobeNewswire Inc.
Tel Aviv, Israel, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (
Medigus: Jeffs’ Brands Ltd. Announces Closing of $15.5 Million Initial Public Offering
12:30pm, Thursday, 01'st Sep 2022 GlobeNewswire Inc.
As a result of the closing, Medigus now owns 35.27% of Jeffs' Brands
Medigus: Gix Internet Reports Revenues Increase of 166% Year-over-Year to Approximately $43.4 Million in the First Half of 2022
12:41pm, Tuesday, 30'th Aug 2022 GlobeNewswire Inc.
Medigus' financials results for the first half of 2022 will include, for the first time, the consolidation of Gix Internet‘s financials
Medigus: Jeffs’ Brands Ltd. Announces Pricing of $15.5 Million Initial Public Offering
01:30pm, Monday, 29'th Aug 2022 GlobeNewswire Inc.
Tel Aviv, Israel, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle a
Medigus' Polyrizon Inks Agreement To Develop Therapies For Traumatic Spinal Cord Injuries
09:07am, Monday, 18'th Jul 2022
Polyrizon Ltd, in which Medigus Ltd (NASDAQ: MDGS) owns a 37.03% stake, signed a binding Collaboration Agreement with NurExone Biologic Inc for therapies for traumatic spinal cord injuries. Pol
Medigus: Eventer Signs Agreements with Two Teams from the Israeli Basketball Premier League and the Israeli National Basketball League
12:30pm, Friday, 01'st Jul 2022 GlobeNewswire Inc.
Eventer will leverage its capabilities in the sports sector and intends to expand its outreach to leagues in the US and Europe
Medigus: ScoutCam Signs a Joint Development Agreement to Equip Aerial Platforms of a Top Global Defense and Aviation Manufacturer with In-Flight Monitoring Solutions
12:50pm, Tuesday, 28'th Jun 2022 GlobeNewswire Inc.
Tel Aviv, Israel, June 28, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and ele
Medigus Announces Receipt of Nasdaq Notice of Bid Price Deficiency
08:01pm, Friday, 17'th Jun 2022 GlobeNewswire Inc.
Tel Aviv, Israel, June 17, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and elec
Medigus: Polyrizon’s PL-15 Found Effective Against Highly Transmissible SARS-CoV-2 Omicron Variant in Cell Culture Assays
01:30pm, Tuesday, 05'th Apr 2022 GlobeNewswire Inc.
The results are consistent with a series of Polyrizon's previous successful tests in human coronavirus 229E and Influenza Virus H1N1 The results are consistent with a series of Polyrizon's previous su
